2. 您的位置
3. 首页
4. 会议论文
5. Lenalidomide alone or in combination with chemotherapy treatment for subtypes of diffuse large B cel

Lenalidomide alone or in combination with chemotherapy treatment for subtypes of diffuse large B cel

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：dlfly2011

【摘 要】

：

Objective: Lenalidomide has been shown to produce durable responses in patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL).In order to gain better understanding of the efficacy

【作 者】

：

Cheng Fang Changping Wu 

【机 构】

：

Department of Oncology, Third Affiliated Hospital of Soochow University

【出 处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年4期

【关键词】

：

Diffuse large B cell lymphoma lenalidomide meta-an 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: Lenalidomide has been shown to produce durable responses in patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL).In order to gain better understanding of the efficacy of lenalidomide and compared the difference in clinical outcome between two subtypes of DLBCL.

其他文献

Translating lab research to clinical immunotherapy of lymphoma

Since the approval of first generation CD20antibody, rituximab, lab research has quickly brought second and third generation of CD20 antibodies (ofatumumab and obinutuzumab) to clinical immunotherapy

会议

lymphomaimmunotherapy

Quadruple Squamous Cell Carcinoma after allogeneic hematopoietic stem-cell transplantation for Leuke

Objective: We experienced a rare case of quadruple squamous cell carcinoma of the gut mucosa and skin after allogeneic hematopoietic stem-cell transplantation for Leukemia.

会议

hematopoietic cell transplantation (HSCT)

PD-1 blockade can restore functions of T-cells in Epstein-Barr virus-positive diffuse large B-cell l

Objective: Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+DLBCL) is an aggressive malignancy that is largely resistant to current therapeutic regimens and is an attractive target for i

会议

T cell exhaustionEBV positive DLBCLmicroenvironm

Predictive Value of Interim FDG-PET/CT Interpreted with Deauville 5-point Score in Diffuse Large B-c

Objective: The aim of this study was to evaluate the prognostic value of interim positron emission tomography/computed tomography (PET/CT) interpreted using the Deauville 5-point score in patients wit

会议

diffuse large B cell lymphomaearly response asses

肾脏粘液样小管状和梭形细胞癌的临床病理特征

目的：探讨肾脏粘液样小管状和梭形细胞癌的临床病理学特征及诊断、鉴别诊断要点。方法：观察1例肾脏粘液样小管状和梭形细胞癌的HE及免疫组化形态特点，分析临床资料，并结合文献讨论。结果：肾脏粘液样小管状和梭形细胞癌镜下表现为排列成簇的狭长小管状的上皮细胞，中间充满粘液间质和梭形细胞，肿瘤细胞温和，核分裂象少见。

会议

肾肿瘤诊断病理学

肾门肿瘤腔镜肾部分切除术探讨-附10例报告

目的：探讨肾门肿瘤腔镜下肾部分切除术的可行性和围手术期处理。方法：回顾性分析我中心2014年7月至2015年1月肾门肿瘤患者行腔镜下肾部分切除术围手术期的临床特征，手术相关指标和并发症等资料，探讨肾门肿瘤行腔镜下肾部分切除术的可行性和技术难点，围手术期处理的注意事项。

会议

肾门肿瘤肾部分切除术腹腔镜

血清人附睾蛋白4水平与肾功能的关系研究

目的：探讨血清人附睾蛋白HE4水平与患者肾功能的关系。方法：通过检测160例肾功能受损患者的血清人附睾蛋白4(HE4)、糖类抗原125(CA125)、尿素氮(BUN)、肌酐(CRE)、胱抑素C(CysC)水平，计算患者ROMA指数和内生肌酐清除率(Ccr)，比较肾功能受损患者的血清HE4水平、CA125水平、ROMA指数与BUN、CRE、Cys C、Ccr的相关性及性别差异，并比较不同Ccr值分组

会议

人附睾蛋白4肾功能

不可逆性电穿孔对裸鼠宫颈癌移植瘤血管生成的影响

目的：研究不可逆性电穿孔(IRE)对宫颈癌肿瘤血管生成的影响及其机制。方法：以HeLa细胞建立宫颈癌荷瘤裸鼠模型15只,固定外加电场脉冲个数15个、脉宽100μs、频率1Hz,根据电压的不同将裸鼠随机分为对照组、低剂量组(800V)、中等剂量组(1000V)和高剂量组(1200V),分别给予相应处理；一周后HE染色和电镜观察肿瘤的组织形态学变化,免疫组化测定组织内微血管密度(MVD)的变化,PCR

会议

不可逆性电穿孔宫颈癌血管生成

Survival spectrum of patients with primary refractory DLBCL: standard salvage chemotherapy might not

Objective: Addition of theanti-CD20 monoclonal antibody Rituximab to chemotherapies has improved the outcome of DLBCL with over 50% of patients achieving long-term survival.

会议

DLBCLRefractoryC myc

Prognostic value of interim 18F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-base

Objective: The prognostic value of an interim fluorine-18-fluorodeoxyglucose positron emission tomogramphy (18F-FDG PET) for diffuse large B-cell lymphoma (DLBCL) has been assessed by different groups

会议

18F-FDG PETDLBCLprognosis